Todd Vanderah

Todd Vanderah

University of Arizona - Tucson / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 1740628
person_outline Todd Vanderah's MOST POPULAR ARTICLES
1-) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioidsMM Ibrahim, F Porreca, J Lai, PJ Albrecht, FL Rice, A Khodorova, G Davar, ...Proceedings of the National Academy of Sciences 102 (8), 3093-3098, 20056342005
2-) Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNSMM Ibrahim, H Deng, A Zvonok, DA Cockayne, J Kwan, HP Mata, ...Proceedings of the National Academy of Sciences 100 (18), 10529-10533, 20035792003
3-) Unmasking the tonic-aversive state in neuropathic painT King, L Vera-Portocarrero, T Gutierrez, TW Vanderah, G Dussor, J Lai, ...Nature neuroscience 12 (11), 1364-1366, 20095312009
4-) CB2 cannabinoid receptor-mediated peripheral antinociceptionTP Malan Jr, MM Ibrahim, H Deng, Q Liu, HP Mata, T Vanderah, F Porreca, ...Pain 93 (3), 239-245, 20015212001
5-) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2, 3-dihydrobenzo [b][1, 4] dioxin-6-yl) acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic propertiesNR Gavva, R Tamir, Y Qu, L Klionsky, TJ Zhang, D Immke, J Wang, D Zhu, ...Journal of Pharmacology and Experimental Therapeutics 313 (1), 474-484, 20054542005